Neuropathy Clinical Trial
Official title:
Data Collection of Standard Care of Patients in the EMG Section
Background: Most people who are referred to the EMG (Electromyography) Section of the NIH are enrolled into specific active studies. This allows researchers to learn about a range of rare neuromuscular disorders. But study criteria may not give researchers the chance to evaluate a single person or study a common symptom. Therefore, researchers want to assess people with neuromuscular disorders who are not currently enrolled in any NIH studies. They will perform tests on these individuals in the EMG Lab. Then they will create a repository of data that may be used for future research. This will help them learn more about these disorders. Objective: To retain data that is collected as part of participant visits to the NIH. Eligibility: People aged 18 and older who will be visiting the NIH for evaluation of their neuromuscular disorder. Design: Participants will be screened with a medical record review. Participants will have a physical exam. They will be evaluated for their neuromuscular disorder. They may have tests to learn more about how their nerves and muscles work that are called nerve conduction and EMG studies. Their muscles and nerves may be assessed with an ultrasound. Their ability to sweat may be measured. Their heart rate and blood pressure may be taken. Changes to their breathing or changes in their body position may be measured. Participant data will be given a unique numerical identifier that can be used if the data is shared. Data will be stored on a server and in a database. Participants will have 1-2 visits. Each visit will last less than 4 hours. They may be contacted for a follow-up visit.
Status | Recruiting |
Enrollment | 200 |
Est. completion date | May 1, 2031 |
Est. primary completion date | May 1, 2031 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 110 Years |
Eligibility | - INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: - The patient or the patient's Legally Authorized Representative is capable of informed consent and signs the consent form. - Male or female, age 18 and over, no age limit - Possible neuromuscular disorder or neurodegenerative disorder. EXCLUSION CRITERIA: No other exclusion criteria for patients |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Neurological Disorders and Stroke (NINDS) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To provide a repository of information on enrolled participants to allow for hypothesis generation in future research. | Results of patient's studies will be tabulated. | 10 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03195868 -
Photobiomodulation Therapy and Nerve Density for Patients With Diabetic or Chemotherapy-associated Neuropathy
|
N/A | |
Not yet recruiting |
NCT05565469 -
Correlation Between Abdominal Wall Stimulation and Neurostimulator Tip Location
|
N/A | |
Completed |
NCT02309164 -
The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).
|
N/A | |
Completed |
NCT00775645 -
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
|
Phase 3 | |
Completed |
NCT03624426 -
Detection and Prevention of Nerve Injury in Shoulder Arthroplasty Surgery
|
N/A | |
Withdrawn |
NCT03436680 -
Home-Based Neurofeedback Program in Treating Participants With Chemotherapy-Induced Peripheral Neuropathy
|
N/A | |
Completed |
NCT05691738 -
Effects of Modified Otago Exercises in Individuals With Diabetic Neuropathy
|
N/A | |
Completed |
NCT05095870 -
Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies
|
||
Completed |
NCT02615678 -
Acupuncture for CIPN in Breast Cancer Patients
|
N/A | |
Completed |
NCT02011282 -
Electro-Neuro-Muscular Stimulation in ICU
|
N/A | |
Recruiting |
NCT01774058 -
The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation
|
Phase 2 | |
Completed |
NCT01135251 -
Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy
|
Phase 2 | |
Recruiting |
NCT06324344 -
Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN)
|
N/A | |
Recruiting |
NCT04403802 -
Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy
|
N/A | |
Recruiting |
NCT04579406 -
Perioperative Adverse Cardiovascular Event in Type-2 Diabetic Patients
|
||
Recruiting |
NCT03881930 -
Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy
|
N/A | |
Completed |
NCT03909464 -
Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy
|
||
Completed |
NCT01523132 -
Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms
|
N/A | |
Completed |
NCT02689661 -
Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects
|
||
Terminated |
NCT00998738 -
Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer
|
Phase 3 |